CRRTnet: a prospective, multi-national, observational study of continuous renal replacement therapy practices
- PMID: 28683729
- PMCID: PMC5501006
- DOI: 10.1186/s12882-017-0650-2
CRRTnet: a prospective, multi-national, observational study of continuous renal replacement therapy practices
Abstract
Background: Continuous renal replacement therapy (CRRT) is the recommended modality of dialysis for critically ill patients with hemodynamic instability. Yet there remains significant variability in how CRRT is prescribed and delivered, and limited evidence-basis to guide practice.
Methods: This is a prospective, multi-center observational study of patients undergoing CRRT. Initial enrollment phase will occur at 4 academic medical centers in North America over 5 years, with a target enrollment of 2000 patients. All adult patients (18-89 years of age) receiving CRRT will be eligible for inclusion; patients who undergo CRRT for less than 24 h will be excluded from analysis. Data collection will include patient characteristics at baseline and at time of CRRT initiation; details of CRRT prescription and delivery, including machine-generated treatment data; and patient outcomes.
Discussion: The goal of this study is to establish a large comprehensive registry of critically ill adults receiving CRRT. Specific aims include describing variations in CRRT prescription and delivery across quality domains; validating quality measures for CRRT care by correlating processes and outcomes; and establishing a large registry for use in quality improvement and benchmarking efforts. For initial analyses, some particular areas of interest are anticoagulation protocols; approach to fluid overload; CRRT-related workload; and patient safety.
Trial registration: Registered on ClinicalTrials.gov 1/10/2014: NCT02034448.
Keywords: Acute kidney injury; Continuous renal replacement therapy; Critical care; Quality.
Conflict of interest statement
Ethics approval and consent to participate
The study was reviewed and approved by the local institutional review board (IRB) for each participating site. In all cases, a waiver for informed consent was granted due to the observational nature of the study. The names of each IRB and specific reference number for CRRTnet are as follows:
- University of Michigan IRB-Med (HUM00074701)
- University of Alberta Health Research Ethics Board (File # Pro00038405)
- Western University Research Ethics Board (File # 103957)
- University of Mississippi Medical Center IRB (#2013–0190)
- Cincinnati Children’s Hospital Medical Center (#2014–5675)
Consent for publication
Not applicable.
Competing interests
SMB and AAH have consulted for and received speaking fees from Baxter Healthcare Corp.
All other authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Intensity of continuous renal replacement therapy for acute kidney injury.Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD010613. doi: 10.1002/14651858.CD010613.pub2. Cochrane Database Syst Rev. 2016. PMID: 27699760 Free PMC article.
-
Intervention measures to improve the filter life of continuous renal replacement therapy in critically ill patients-A systematic review.Nurs Crit Care. 2025 Jul;30(4):e13225. doi: 10.1111/nicc.13225. Epub 2024 Dec 9. Nurs Crit Care. 2025. PMID: 39651631
-
Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review.Crit Care. 2014 Dec 8;18(6):675. doi: 10.1186/s13054-014-0675-x. Crit Care. 2014. PMID: 25482187 Free PMC article.
-
Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.Crit Care. 2016 Nov 19;20(1):374. doi: 10.1186/s13054-016-1551-7. Crit Care. 2016. PMID: 27863531 Free PMC article.
-
The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.BMC Nephrol. 2017 Oct 2;18(1):304. doi: 10.1186/s12882-017-0718-z. BMC Nephrol. 2017. PMID: 28969597 Free PMC article.
Cited by
-
Extracorporeal therapies in sepsis: a comprehensive review of the Selective Cytopheretic Device, Polymyxin B and Seraph cartridges.Ren Fail. 2025 Dec;47(1):2459349. doi: 10.1080/0886022X.2025.2459349. Epub 2025 Feb 17. Ren Fail. 2025. PMID: 39962644 Free PMC article. Review.
-
Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study.Kidney Med. 2023 Apr 15;5(6):100641. doi: 10.1016/j.xkme.2023.100641. eCollection 2023 Jun. Kidney Med. 2023. PMID: 37274539 Free PMC article.
-
The Impact of the Selective Cytopheretic Device on Neutrophil-to-Lymphocyte Ratios and Hematological Parameters in Acute Kidney Injury: A Pooled Analysis.Nephron. 2025 May 30:1-13. doi: 10.1159/000546528. Online ahead of print. Nephron. 2025. PMID: 40451159 Free PMC article.
-
Management of renal replacement therapy among adults in French intensive care units: A bedside practice evaluation.J Intensive Med. 2023 Jan 13;3(2):147-154. doi: 10.1016/j.jointm.2022.10.005. eCollection 2023 Apr 30. J Intensive Med. 2023. PMID: 37188118 Free PMC article.
-
Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era?Kidney Dis (Basel). 2019 Mar;5(2):69-80. doi: 10.1159/000495139. Epub 2018 Dec 19. Kidney Dis (Basel). 2019. PMID: 31019921 Free PMC article. Review.
References
-
- Herrera-Gutierrez ME, Seller-Perez G, Sanchez-Izquierdo-Riera JA, Maynar-Moliner J. Prevalence of acute kidney injury in intensive care units: the "COrte de prevalencia de disFuncion RenAl y DEpuracion en criticos" point-prevalence multicenter study. J Crit Care. 2013;28(5):687–694. doi: 10.1016/j.jcrc.2013.05.019. - DOI - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical